Metraipolis › archive › dc_98e5b71bc2bf
Drawbacks of Olanzapine Therapy: An Emphasis on Its Metabolic Effects and Discontinuation — Europe PMC PMID:41303162
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41303162
- DOI
- 10.3390/jcm14228125
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T12:32:00.586Z
- SHA-256 of the archived text
f51ba80fcad6b464ba08c70ee27eddc716e05d973d24121913dc978ebbb2fa9c- Stable URL of this page
https://metraipolis.com/documento/dc_98e5b71bc2bf
How to cite
Drawbacks of Olanzapine Therapy: An Emphasis on Its Metabolic Effects and Discontinuation — Europe PMC PMID:41303162 — Europe PMC (en), https://europepmc.org/article/MED/41303162 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_98e5b71bc2bf (Metraipolis archive dc_98e5b71bc2bf, sha256 f51ba80fcad6b464ba08c70ee27eddc716e05d973d24121913dc978ebbb2fa9c)
BibTeX
@misc{dc98e5b71bc2bf,
title = {Drawbacks of Olanzapine Therapy: An Emphasis on Its Metabolic Effects and Discontinuation — Europe PMC PMID:41303162},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41303162},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_98e5b71bc2bf; sha256 f51ba80fcad6b464ba08c70ee27eddc716e05d973d24121913dc978ebbb2fa9c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41303162. Agents can read the archived copy with the MCP tool read_document.